We have previously reported that the administration of a large amount of di(n-butyl)phthalate (DBP) increased the conversion ratio of tryptophan to niacin in rats. In the present experiment, the eŠect of di(2-ethylhexyl)phthalate (DEHP) on the conversion ratio and how altering the conversion ratio of tryptophan to niacin depended on the concentration of DEHP were investigated to elucidate the toxic mechanism of phthalic acid esters (PhE). Rats were fed with a diet containing 0%, 0.01%, 0.05%, 0.1%, 0.5%, 1.0%, or 3.0% DEHP for 21 days. To assess the conversion ratio of tryptophan to niacin, urine samples were collected at the last day of the experiment and measured for metabolites on the tryptophan-niacin pathway. The conversion ratio increased with increasing dietary concentration of DEHP above 0.05%; the conversion ratio was about 2% in the control group, whereas it was 28% in the 3.0% DEHP group. It is suggested that the inhibition of a-aminob-carboxymuconate-e-semialdehyde decarboxylase (ACMSD) by DEHP or its metabolites caused this increase in the conversion ratio. We conclude that PhE such as DEHP and DBP disturbed the tryptophanniacin metabolism.
We have previously reported that the administration of a large amount of di(n-butyl)phthalate (DBP) increased the conversion ratio of tryptophan to niacin in rats. In the present experiment, the eŠect of di(2-ethylhexyl)phthalate (DEHP) on the conversion ratio and how altering the conversion ratio of tryptophan to niacin depended on the concentration of DEHP were investigated to elucidate the toxic mechanism of phthalic acid esters (PhE). Rats were fed with a diet containing 0%, 0.01%, 0.05%, 0.1%, 0.5%, 1.0%, or 3.0% DEHP for 21 days. To assess the conversion ratio of tryptophan to niacin, urine samples were collected at the last day of the experiment and measured for metabolites on the tryptophan-niacin pathway. The conversion ratio increased with increasing dietary concentration of DEHP above 0.05%; the conversion ratio was about 2% in the control group, whereas it was 28% in the 3.0% DEHP group. It is suggested that the inhibition of a-aminob-carboxymuconate-e-semialdehyde decarboxylase (ACMSD) by DEHP or its metabolites caused this increase in the conversion ratio. We conclude that PhE such as DEHP and DBP disturbed the tryptophanniacin metabolism.
Key words: phthalic acid ester; di(2-ethylhexyl)phthalate; conversion ratio of tryptophan to niacin; endocrine disrupter; niacin toxicity Phthalic acid esters (PhE) are used in the industrial production of lubricants, glues, insect repellents, dielectric ‰uids, and plastics. 1) Among the phthalate esters, di(2-ethylhexyl) phthalate (DEHP) is one of the most frequently used additives in the manufacture of elastic polyvinyl chloride.
2) Many studies have demonstrated that treating rats with DEHP induced testicular atrophy with liver enlargement, 2, 3) although the precise nature and mechanism for the action of DEHP on these organs has remained unclear.
To clarify the mechanism for the toxicity of PhE, Shibata et al. 4) have found that the growth of weaning rats fed with a niacin-free and tryptophan (Trp)-limited diet was promoted by the administration of di-n-butylphtalate (DBP). Furthermore, they revealed that the conversion of Trp to niacin was signiˆcantly promoted by feeding with the DBP diet.
5)
However, it is not known whether this is common phenomenon associated with PhE, since the eŠects of PhE on living bodies are not the same; for example, DEHP induced liver enlargement and proliferation of hepatic peroxisomes, while di-n-hexylphthalate caused no peroxisome proliferation but caused fat accumulation in the liver. 6) We therefore investigated whether or not DEHP, one of the most frequently used PhE, would also increase the conversion ratio of Trp to niacin, and how this conversion ratio depended on the amount of dietary DEHP administrated.
Materials and Methods
Chemicals. NAD + was purchased from Sigma Chemical Company (St. Louis, MO, U.S.A.). Vitamin-free milk casein, sucrose, L-methionine, Nam, Trp, and AnA were purchased from Wako Pure Chemical Industries (Osaka, Japan). Kynurenine sulfate, MNA chloride, XA, KA, and 3-HA were obtained from Tokyo Kasei Kogyo (Tokyo, Japan). 2-Py and 4-Py were respectively synthesized by the methods of Pullman and Colowick 7) and of Shibata et al. 8) The mineral and vitamin mixtures were obtained from Oriental Yeast Kogyo (Tokyo, Japan). All other chemicals used were of the highest purity available from commercial sources. 
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Animals and diets. The animal room was maintained at a temperature of around 229 C and at about 60z humidity with a 12-hr light W 12-hr dark cycle. Body weight and food intake were measured daily at around 10:00 a.m., and food and water were renewed daily.
The care and treatment of the experimental animals conformed to The University of Shiga Prefecture guidelines for the ethical treatment of laboratory animals. Male rats of the Wistar strain (6 weeks old) were obtained from Clea Japan (Tokyo, Japan) and immediately placed in individual metabolic cages (CT-10; Clea Japan). They were then divided into seven groups, and fed ad libitum for 21 days (Table 1) . Urine samples on the last day (10:00 a.m.-10:00 a.m.; 24-hr urine) were collected in amber bottles with 1 ml of 1 M HCl and stored at "259 C until needed for use. The rats were killed by decapitation after the last urine samples had been collected, a 10-ml sample of blood was taken from the carotid artery, and the liver was removed.
Analysis. The contents of Nam, 2-Py, and 4-Py in the urine were simultaneously measured by the HPLC method of Shibata et al., 8) while the content of MNA in the urine was measured by the HPLC method of Shibata.
10)
The contents of KA, 11) XA, 12) 3-HA 12) and AnA 13) in the urine were measured by conventional HPLC methods. The concentrations of NAD (NAD + +NADH) and NADP (NADP + +NADPH) in the blood and liver were respectively measured by the colorimetric method of Shibata and Murata, 9) and by the method of Shibata and Tanaka. 14) Statistical analysis. Each data value is expressed as the mean±SEM. DiŠerences between groups were determined by ANOVA. If signiˆcance was indicated, the Student-Newman-Keuls post hoc test was used to determine where the signiˆcance occurred, Pº0.05 being considered statistically signiˆcant.
Results
EŠect of various concentrations of DEHP on the body weight gain, food intake, and liver weight A 0.01-0.5z amount of DEHP in the diet did not aŠect the body weight or food intake (Figs. 1(A) and  1(B) ). The body weight gain and food intake of the rats fed on 1.0z and 3.0z DEHP were signiˆcantly lower than in the other groups (Figs. 1(A) and 1(B) ). The liver weight increased with increasing DEHP concentration ( Fig. 1(C) ).
EŠect of various concentrations of DEHP on the NAD and NADP contents in the liver and blood
The liver content of NAD (NAD + +NADH) was signiˆcantly higher in the 0.1-3.0z DEHP groups, but not in the 0.01z and 0.05z groups, than in the control group (Fig. 2(A) ). 0.5-3.0z, but not 0.01-0.1z, DEHP in the diet increased the liver content of NADP (NADP + +NADPH) (Fig. 2(B) ). The concentrations of blood NAD and NADP were not aŠected by feeding DEHP (Figs. 2(C) and  2(D) ).
EŠect of various concentrations of DEHP on the urinary excretion of upper metabolites on the Trpniacin pathway
The urinary outputs of anthranilic acid (AnA), kynurenic acid (KA), xanthurenic acid (XA), and 3-hydroxyanthranilic acid (3-HA) are expressed in terms of nmol W g of diet, since the food intake was not the same among the groups. The AnA output to urine was not aŠected in the 0.01-1.0z DEHP groups, XA was not aŠected in the 0.01-0.5z groups, and KA and 3-HA were not aŠected by DEHP (Fig. 3) .
EŠect of various concentrations of DEHP on the urinary excretion of lower metabolites on the Trp- Under the present experimental conditions, QA, Nam, MNA, 2-Py, and 4-Py originated from dietary Trp, since the diets were niacin-free. The urinary output of QA formed from 3-HA increased with increasing dietary concentration of DEHP (Fig. 4(A) ), although the urinary 3-HA output was not aŠected (Fig. 3(D) ). Nam is a direct catabolic metabolite of NAD and NADP, Nam being metabolized to MNA which is then metabolized to 2-Py or 4-Py. MNA, 2-Py, and 4-Py are not niacin-active compounds. The outputs of these compounds were also increased by feeding DEHP (Figs. 4(B) , 4(C), 4(D) and 4(E)).
EŠect of various concentrations of DEHP on the conversion ratio of Trp to niacin
The conversion ratio of Trp to niacin increased with increasing dietary DEHP concentration (Fig. 5) . A severely adverse eŠect was observed in the group fed with the 3.0z DEHP diet as determined by the data for the body weight and food intake (Fig. 1) . Under these conditions, the conversion ratio reached 28z (Fig. 5) , this value being about 14-fold higher than the value of 2z in the control group.
Discussion
We have previously reported that DBP, a plasticizer and phthalic acid ester, increased the conversion ratio of Trp to niacin, 5) and that the growth of weaning rats fed with a niacin-deˆcient diet was signiˆcantly promoted by adding DBP. 4) In the present study, DEHP also increased the conversion ratio with increasing concentration of more than 0.05z. The addition of 1z DBP to the niacin-free, 20z casein diet increased the conversion ratioˆve-fold, 5) while 1.0z DEHP increased it seven-fold, and 3.0z DEHP increased itˆfteen-fold. Theseˆndings demonstrate that feeding a phthalic acid ester such as DBP and DEHP disturbed the Trp-niacin metabolism. Whether other phE however, would aŠect the Trp-niacin metabolism remains to be elucidated.
Trp-niacin metabolism follows two pathways, the Trp-a-amino-b-carboxymuconate-e-semialdehyde (ACMS) pathway and ACMS-niacin pathway, since the Trp-niacin pathway branches at ACMS into the ACMS-acetyl CoA pathway and ACMS-niacin pathway. ACMS metabolized to a-aminomuconate-esemialdehyde is led to the ACMS-acetyl CoA pathway by aminocarboxymuconatesemialdehyde decarboxylase (ACMSD), while ACMS is spontaneously cyclized to QA. 15) It is considered that QA formation and QA metabolism are the important regulatory events on the Trp-niacin pathway, and that ACMSD and quinolinate phosphoribosyltransferase (QPRT) are the rate-limiting enzymes on the Trp-niacin pathway. [16] [17] [18] [19] In the present study, the urinary excretion of the metabolites, AnA, KA, XA and 3-HA, on the Trp-ACMS pathway was not aŠected by feeding DEHP, whereas DEHP feeding increased the metabolites, QA, Nam, MNA, 2-Py and 4-Py, on the ACMS-niacin pathway. These results suggest that DEHP aŠected ACMSD to form QA. DEHP or its metabolites may inhibit ACMSD activity or gene expression of ACMSD. Although phthalic acid, a hydrolysis product of DEHP, inhibited QPRT activity, [20] [21] [22] [23] DEHP seem unlikely to have decreased the formation of lower metabolites from QA. In fact, feeding DBP did not aŠect the liver QPRT activity. 5) Some amount of niacin is needed to maintain a healthy body, but an excess of niacin causes an adverse eŠect. 24) Supplementation of the diet with 1z Nam in rats caused growth inhibition. 25) A similar phenomenon has been reported that growth retardation was observed with about 50 mg (400 mmol) of Nam W 100 g of body weight W day in rats. 26) 3.0z DEHP in the diet increased the conversion ratio of Trp to niacin to 28z. This means that about 16 mmol W 100 g of body weight W day of niacin was biosynthesized to form Trp, whereas the rats fed on the control diet biosynthesized 1.6 mmol of niacin W 100 g of body weight W day. In the case of administering excess niacin, most of this niacin is soon excreted into the urine, and the utilization rate is low. 27) Therefore, whether or not the amount of niacin causes an adverse eŠect might depend on its origin, i.e., endogenously synthesized or exogeneously administered. Although little is known about the relationship between the amount of biosynthesized niacin and its adverse eŠect, there is the possibility that the increased conversion ratio by DEHP causes an adverse eŠect. DEHP induced testicular atrophy with liver enlargement. 2, 3) However, it is unclear whether excess biosynthesized niacin aŠected the testis or liver. More work is needed to clarify the relationship between the eŠect of DEHP and niacin metabolism.
In summary, the conversion ratio of Trp to niacin increased with increasing on the dietary concentration of DEHP. This phenomenon was observed at a DEHP concentration of more than 0.05z. Thus, DEHP activated the ACMS-niacin pathway, and not the Trp-ACMS pathway, suggesting the inhibition of ACMSD by DEHP or its metabolites. We conclude that such PhE compounds as DEHP and DBP disturbed the Trp-niacin metabolism.
